World Investment Advisors Makes New $217,000 Investment in Nutex Health Inc. (NASDAQ:NUTX)

World Investment Advisors purchased a new stake in shares of Nutex Health Inc. (NASDAQ:NUTX - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 6,852 shares of the company's stock, valued at approximately $217,000. World Investment Advisors owned approximately 0.13% of Nutex Health as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. American Century Companies Inc. purchased a new stake in shares of Nutex Health in the 4th quarter worth approximately $1,362,000. Drive Wealth Management LLC bought a new stake in Nutex Health in the fourth quarter worth $1,122,000. Essex Investment Management Co. LLC increased its holdings in shares of Nutex Health by 45.4% during the fourth quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company's stock valued at $3,353,000 after acquiring an additional 33,024 shares in the last quarter. State Street Corp purchased a new position in shares of Nutex Health in the 3rd quarter worth about $225,000. Finally, Legato Capital Management LLC boosted its stake in Nutex Health by 26.8% in the 4th quarter. Legato Capital Management LLC now owns 31,669 shares of the company's stock worth $1,004,000 after purchasing an additional 6,697 shares in the last quarter. 5.32% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, Maxim Group lifted their target price on shares of Nutex Health from $75.00 to $100.00 and gave the stock a "buy" rating in a report on Tuesday, April 8th.

Insider Activity at Nutex Health

In related news, CFO Jon Christian Bates bought 1,000 shares of the stock in a transaction that occurred on Tuesday, April 8th. The shares were bought at an average cost of $81.81 per share, for a total transaction of $81,810.00. Following the completion of the transaction, the chief financial officer now owns 4,888 shares of the company's stock, valued at approximately $399,887.28. This trade represents a 25.72 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 38.52% of the stock is currently owned by company insiders.

Nutex Health Stock Performance

NUTX traded up $0.69 during mid-day trading on Tuesday, reaching $130.36. 67,093 shares of the company traded hands, compared to its average volume of 62,542. The company's fifty day moving average price is $64.12 and its 200-day moving average price is $42.85. The stock has a market capitalization of $720.60 million, a P/E ratio of -13.83 and a beta of 0.27. The company has a quick ratio of 1.74, a current ratio of 1.77 and a debt-to-equity ratio of 3.36. Nutex Health Inc. has a 52-week low of $4.16 and a 52-week high of $137.32.

Nutex Health (NASDAQ:NUTX - Get Free Report) last posted its earnings results on Monday, March 31st. The company reported $11.12 earnings per share for the quarter, beating analysts' consensus estimates of ($0.09) by $11.21. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%. The company had revenue of $81.30 million for the quarter, compared to the consensus estimate of $81.13 million.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.